Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03055442
Other study ID # MI/DCI_FF
Secondary ID
Status Completed
Phase N/A
First received February 8, 2017
Last updated February 13, 2017
Start date October 2016
Est. completion date December 2016

Study information

Verified date February 2017
Source Lo.Li.Pharma s.r.l
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Considering the importance assumed by follicular microenvironment for a proper oocyte development, this study is a prospective observational clinical trial which aims to evaluate whether the embryo blastocyst quality may be affected by different Myo-inositol (MI) and D-chiro-inositol (DCI) levels in the follicular fluid (FF) of the aspired oocytes. The study includes egg donors and egg receiving couples participating in the oocyte donation program. MI/DCI is calculated in FF and related with blastocyst grade.


Recruitment information / eligibility

Status Completed
Enrollment 34
Est. completion date December 2016
Est. primary completion date November 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 28 Years
Eligibility Inclusion Criteria:

- clear follicular aspirate obtained during oocyte retrieval;

- each specimen of follicular fluid containing only one oocyte.

Exclusion Criteria:

- hyperglycaemic women;

- PCOS women also if euglycaemic;

- diabetic subjects having low concentrations of detectable MI in association with an anomalous MI transport.

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Dosage of myo-inositol
Quantitative analysis of myo-inositol was performed by gas chromatography-mass spectrometry (GC-MS)
Dosage of D-chiro-inositol
Quantitative analysis of D-chiro-inositol was performed by gas chromatography-mass spectrometry (GC-MS)

Locations

Country Name City State
Greece Iakentro Advanced Medical Centre, IVF Unit Thessaloniki

Sponsors (1)

Lead Sponsor Collaborator
Lo.Li.Pharma s.r.l

Country where clinical trial is conducted

Greece, 

References & Publications (3)

Carlomagno G, Unfer V, Roseff S. The D-chiro-inositol paradox in the ovary. Fertil Steril. 2011 Jun 30;95(8):2515-6. doi: 10.1016/j.fertnstert.2011.05.027. — View Citation

Chiu TT, Rogers MS, Law EL, Briton-Jones CM, Cheung LP, Haines CJ. Follicular fluid and serum concentrations of myo-inositol in patients undergoing IVF: relationship with oocyte quality. Hum Reprod. 2002 Jun;17(6):1591-6. — View Citation

Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2000 Jun;73(6):1155-8. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Myo-inositol concentration (µmol/l) in follicular fluid After transvaginal aspiration of oocyte and follicular fluid and subsequent ICSI, at the day 5 the cultured embryos were graded according to Gardner's grading system for blastocysts. Then follicular fluids specimens were divided following the different scores given to the respective blastocysts, and their content in myo-inositol was quantified.
In each sample of follicular fluid myo-inositol levels were assessed. The quantitative analysis was performed by means of gas chromatography-mass spectrometry (GC-MS) and the values were expressed as µmol/l. This value was related to the respective blastocyst grade.
5th day from pick up
Primary D-chiro-inositol concentration (µmol/l) in follicular fluid After transvaginal aspiration of oocyte and follicular fluid and subsequent ICSI, at the day 5 the cultured embryos were graded according to Gardner's grading system for blastocysts. Then follicular fluids specimens were divided following the different scores given to the respective blastocysts, and their content in D-chiro-inositol was quantified.
In each sample of follicular fluid D-chiro-inositol levels were assessed. The quantitative analysis was performed by means of gas chromatography-mass spectrometry (GC-MS) and the values were expressed as µmol/l. This value was related to the respective blastocyst grade.
5th day from pick up
See also
  Status Clinical Trial Phase
Recruiting NCT02398630 - "Magnetic Resonance Imaging Hysterosalpingography for the Integral Evaluation of the Infertile Patient." N/A
Completed NCT03023514 - Lipoic Acid Supplementation in IVF Phase 4
Not yet recruiting NCT03163862 - G-CSF Administration in IVF in a Preferable Preceptive Endometrium Score Phase 2/Phase 3